臨床數據分析市場 - 預測 2023-2028

臨床數據分析市場預計到 2021 年將達到 255.96 億美元，預測期內復合年增長率為 25.74%，到 2028 年將達到 1272.2 億美元。

臨床數據分析收集、存儲、分析和增強敏感臨床數據在臨床研究中的適用性，使護理人員能夠為患者提供預防性和個性化護理。這是實現並從而提高患者護理整體質量的關鍵一步。 向數字支付模式遷移的趨勢和電子病歷 (EMR) 的普及正在推動世界許多地區該市場的增長。 對改進和具有成本效益的醫療保健的需求不斷增長，推動了對臨床數據分析的需求。 隨著主要市場參與者在安全方面投入巨資，數字平台和渠道的安全性不斷提高，醫療保健行業也進行了大量投資，使得臨床數據分析的採用在預測期內繼續獲得動力，推動了市場的增長。 從地域上看，由於有利的政府政策和對大數據分析的巨額投資，北美在全球市場中佔有很大的市場份額。

該研究根據產品、部署、最終用戶和地理位置等各個細分市場進行市場細分。 首先，市場概述詳細介紹了關鍵驅動因素和挑戰。 然後利用波特五力模型對臨床數據分析行業進行全面分析。 然後，價值鏈分析可以確定哪些公司屬於不同流程並為不同領域做出貢獻。

它還提供了有關發展、趨勢、行業政策和影響臨床數據分析市場的政策的深入信息。 此外，該研究還分析了臨床數據分析領域的整體監管框架，並使利益相關者更好地了解影響整體市場格局的關鍵因素。

《臨床數據分析市場 - 2023-2028 年預測》是一份全面的最新報告。 我們向管理層和感興趣的利益相關者提供關鍵市場信息，並讓他們了解關鍵市場信息。 我們還分析了主要市場參與者的競爭格局和詳細策略，並將其繪製在我們的供應商矩陣中的四個像限中：領導者、追隨者、挑戰者和利基市場。

臨床數據分析市場報告的研究範圍和覆蓋範圍如下：

• 臨床數據分析市場前景的市場數據表和圖表，包括市場驅動因素、限制因素、搬運工、行業價值鏈分析市場評估等部分，按產品分類為軟件和服務。 本地和雲部署模型的詳細市場趨勢、分析和圖形表示。 對臨床數據分析市場按最終用戶細分為製藥公司、醫療機構、研究機構和政府機構的深入分析。 它提供了按地區（北美、南美、歐洲、中東/非洲和亞太地區）對臨床數據分析解決方案和服務的360度需求視圖，並進一步細分了該地區的主要國家。

內容

第一章簡介

• 市場概覽
• 市場定義
• 調查範圍
• 市場細分
• 貨幣
• 先決條件
• 基準年和預測年時間表

第 2 章研究方法

• 調查數據
• 調查設計
• 驗證

第 3 章執行摘要

• 調查要點

第 4 章市場動態

• 市場驅動因素
• 市場製約因素
• 波特五力分析
• 行業價值鏈分析

第 5 章臨床數據分析市場：按產品

• 簡介
• 軟件
• 服務

第 6 章臨床數據分析市場：按部署模型

• 簡介
• 本地
• 雲

第 7 章臨床數據分析市場：按最終用戶劃分

• 簡介
• 製藥公司
• 醫療機構
• 研究機構
• 政府機構

第 8 章臨床數據分析市場：按地區

• 簡介
• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙特阿拉伯
  • 阿拉伯聯合酋長國
  • 以色列
  • 其他
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 韓國
  • 印度尼西亞
  • 泰國
  • 其他

第 9 章競爭格局與分析

• 主要公司及戰略分析
• 新興公司和市場盈利能力
• 合併、收購、協議與合作
• 供應商競爭力矩陣

第 10 章公司簡介

• McKesson Corporation
• Optum, Inc.
• IBM
• Oracle
• SAS Institute, Inc.
• IQVIA
• Elsevier
• Allscripts Healthcare Solutions, Inc.
• Medical Information Technology Inc.
• CareCloud Corporation

The clinical data analytics market was valued at US$25.596 billion in 2021 and is projected to expand at a CAGR of 25.74% over the forecast period to reach US$127.220 billion by 2028.

Clinical data analytics is an important phase in clinical research that involves the collection, storage, and analysis of sensitive clinical data to enhance its applicability, thus aiding caregivers in providing preventive and personalized care to the patients, thereby improving the overall quality of patient care. Shifting trends toward digital payment models and the growing popularity of Electronic Medical Records (EMRs) are driving the growth of this market in many regions across the globe. Rising demand for improved and cost-effective healthcare is increasing the demand for clinical data analytics. As the security of digital platforms and channels continues to increase owing to huge amounts being poured into security by major market players, and significant investments continue to stream into the healthcare industry, the adoption of clinical data analytics will continue to gain momentum over the projected period, thus augmenting the growth of this market. Geographically, North America holds a significant market share in the global market on account of favorable government policies and huge investments in big data analytics.

This research study examines the clinical data analytics market based on various segments: product, deployment, end-user, and geography. First, a brief overview of the market details key driving factors and challenges. Next, Porter's five forces model analyzes the Clinical data analytics industry comprehensively. This is followed by industry value chain analysis which determines the companies which are part of the different processes and contributing to various sectors.

The study also presents in-depth information concerning the development, trends, and industry policies and regulations affecting the clinical data analytics market. Moreover, the research study analyzes the overall regulatory framework of the Clinical data analytics sector, offering stakeholders a better understanding of the key factors influencing the overall market environment.

Clinical data analytics market - Forecasts from 2023 to 2028 are a comprehensive and latest report. It provides vital market information to executives and interested stakeholders to enable them to get vital market information. The report also analyzes the competitive landscape and details strategies of key market players and also plots them on our vendor matrix in four quadrants: leader, follower, challenger, and niche.

The scope and coverage of the clinical data analytics market report are as below:

• Clinical data analytics market data tables and charts
• Market outlook with sections on drivers, restraints, Porter's, and industry value chain analysis
• Market assessment by product into software and services.
• Detailed market trends, analysis, and graphical representation by deployment model into on-premise and cloud.
• In-depth analysis of the clinical data analytics market by end-user into pharmaceutical companies, healthcare organizations, research organizations, and government organizations.
• A 360 degree view of the demand for clinical data analytics solutions/services across different geographies (North America, South America, Europe, Middle East and Africa, and Asia Pacific) with further breakdown for key countries within those regions.

Different segments covered under the clinical data analytics market report are as below:

By Product

• Software
• Services

By Deployment Model

• On-Premise
• Cloud

By End-User

• Pharmaceutical Companies
• Healthcare Organizations
• Research Organizations
• Government Organizations

By Geography

• North America
  • United States
  • Canada
  • Mexico
• South America
  • Brazil
  • Argentina
  • Others
• Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Research Design
• 2.3. Validation

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. CLINICAL DATA ANALYTICS MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Software
• 5.3. Services

6. CLINICAL DATA ANALYTICS MARKET BY DEPLOYMENT MODEL

• 6.1. Introduction
• 6.2. On-Premise
• 6.3. Cloud

7. CLINICAL DATA ANALYTICS MARKET BY END-USER

• 7.1. Introduction
• 7.2. Pharmaceutical Companies
• 7.3. Healthcare Organizations
• 7.4. Research Organizations
• 7.5. Government Organizations

8. CLINICAL DATA ANALYTICS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. United Kingdom
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Emerging Players and Market Lucrativeness
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

• 10.1. McKesson Corporation
• 10.2. Optum, Inc.
• 10.3. IBM
• 10.4. Oracle
• 10.5. SAS Institute, Inc.
• 10.6. IQVIA
• 10.7. Elsevier
• 10.8. Allscripts Healthcare Solutions, Inc.
• 10.9. Medical Information Technology Inc.
• 10.10. CareCloud Corporation